As councils across England undergo Local Government Reorganisation (LGR), a new report from the Local Government Association (LGA) shows that this isn’t just a structural change, but it will also create digital opportunities.
Software Consultant Paul Wallace, explains how Pivotal Solutions Limited have cultivated 20 years of success through high quality software and forming good relationships with customers.
Dr Vijay Magon, Managing Director of CCube Solutions, demonstrates here how their project successes and expertise working with the NHS is providing cost-effective and scalable solutions, tailored to meet individual requirements.
This month the UK’s Online Safety Bill will return to Parliament and the news can’t come soon enough for children and young people at risk from online harm and abuse.
Markus Sebastian, Executive Vice President and Managing Director, EMEA, Align Technology, discusses the importance of placing oral health at the forefront of the global healthcare agenda.
Gareth Ellis, the Managing Director at EcoGrit Ltd turns away from damaging products used for gritting, protecting people and the planet in icy conditions.
Coldwater therapy means exposing the body to cold temperatures by immersing the body in cold water. This might be by cold water swimming or taking cold water showers or baths.
Black history in schools continues to be increasingly vital, as decolonising education and improving representation gives students a broader, more honest curriculum delving into systemic inequality.
Reflecting on the recent World Antimicrobial Awareness Week (WAAW 2022), it’s evident that we must continue to raise better awareness and understanding of antimicrobial resistance, which is one of the top 10 global public health threats facing humanity.
Emilie Prouzet, Member of the European Economic and Social Committee, Employers’ Group (Group I), discusses how the cost of non-Europe represents thousands of missed opportunities to deepen the internal market.
After decades of failure for Alzheimer’s researchers, Lecanemab could open the door to a new ear of drugs to treat Alzheimer’s disease – the world's most common form of dementia.
